Tech Enabled Services Overview
Tech Enabled Services from Diaceutics are a suite of services to interface Pharmaceutical companies with clinical testing labs to provide enablement and educational services in novel biomarkers
Experience to drive outcomes
Utilizing Diaceutics' expertise in Precision Medicine and DXRX lab network, we construct and manage virtual advisory boards to drive strategic outcomes aligned to client project goals. Actionable insights are captured in evaluation reporting after the meeting
Increase your reach across multiple Precision Medicine Stakeholders
Engaging multiple Precision Medicine stakeholders including clinicians, pathologists, payers, patient advocacy groups and policy makers around utility of biomarker testing, testing pathways or reimbursement sources
Creating collaboration between Pharmaceutical companies and the lab community
Create and enable a valuable interface for pharmaceutical companies with the lab community and Key Opinion Leaders to explore and reveal new insights essential to commercialization and development of a therapy or companion diagnostic
Select the right EQA partner
DXRX Tech Enabled Services (TES) team work with pharmaceutical companies to select the right EQA partner for their product, recruit labs to participate in the program and provide support and assistance to labs and pharma throughout the project
Promote education among labs on new tests at pre-launch stages
Promote education among labs at pre-launch stages on how to perform new tests and achieve high quality testing standards post-launch
Engage with labs to promote awareness around new biomarkers and technologies
Access a range of direct-to-labs outreach campaigns to promote knowledge and awareness around new biomarkers, technologies and how to implement successful testing
